News

Sandstorm Gold Royalties: It Could Have Been Better (NYSE:SAND)

5 Mins read

Introduction

Vancouver-based Sandstorm Gold Ltd. (SAND) released its third quarter 2023 results on November 6, 2023.

Note: My earlier articles on Sandstorm Gold, which were released on August 14 and October 9, 2023, have been updated in this article. Since

Sandstorm Gold 3Q22 4Q22 1Q23 2Q23 3Q23
Revenues in dollars 38.95 38.45 43.98/53.98* 49.84 41.32
Net Income to shareholders in dollars 31.68 -2.36 15.67 2.05 -0.24
EBITDA in dollars 53.02 30.36 43.77 33.30 26.62
EPS Diluted 0.13 -0.05 0.05 0.01 0.00
Cash From Operating Activities in Millions 25.09 26.27 39.92 42.14 31.95
CAPEX in $million 489.01 88.65 3.35 11.83 2.75
FCF in $million -463.92 -62.38 36.57 30.32 29.20
Total cash in $ million (incl. short-term note) 12.56 10.80 7.92 24.95 13.79
Bank Debt in Millions 524.0 497.5 475.0 467.0 456.0
Shares outstanding diluted in millions 244.75 301.28 301.26 300.67 296.17
Dividend per share in $ 0.015 0.015 0.015 0.015 0.015
Production 3Q22 4Q22 1Q23 2Q23 3Q23
In K Au Eq. 22.61 21.75 28.37 24.50 21.12
Gold price 1,706 1,746 1,882 1,972 1,919

Read the full article here

Related posts
News

ZTR: Hybrid Portfolio With Utility Tilt At A Deep Discount (NYSE:ZTR)

1 Mins read
This article was written by Follow Nick Ackerman is a former financial advisor using his experience to provide coverage on closed-end funds…
News

IJT ETF: Why The Tide May Turn For Small-Cap Growth In 2026 (NASDAQ:IJT)

1 Mins read
This article was written by Follow The Sunday Investor is focused exclusively on U.S. Equity ETFs. He has a strong analytical background,…
News

Ascendis Pharma A/S (ASND) Discusses Week 52 Topline Results From COACH Trial Evaluating TransCon CNP and Growth Hormone in Achondroplasia Transcript

1 Mins read
Follow Play Earnings CallPlay Earnings Call Ascendis Pharma A/S (ASND) Discusses Week 52 Topline Results From COACH Trial Evaluating TransCon CNP and…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *